摘要
①目的 观察美托洛尔治疗充血性心力衰竭的效果。②方法 88例心功能Ⅱ～Ⅲ级住院充血性心力衰竭病人 ,随机分为美托洛尔治疗组 (4 8例 )及对照组 (4 0例 )。对照组给予常规治疗 ;治疗组在常规治疗基础上加用美托洛尔 6 .2 5～ 2 5 .0 0mg/d ,疗程 4周。③结果 治疗 4周后 ,治疗组疗效明显优于对照组 (uc=2 .17,P <0 .0 5 )。④结论 在常规抗心衰治疗基础上加用美托洛尔 ,是一种安全、有效的临床治疗方法。
Objective\ To study the clinical effects of metoprolol for congestive heart failure. \ Methods\ Eighty eight inpatients with congestive heart failure (cardiac function NYHA Ⅱ-Ⅲ class) were divided randomly into two groups: treatment group (48 cases) and control group (40 cases). The routine therapy for the two groups was same , the only difference was that for the treatment group, metoprolol, 6.25-25.00 mg/d, was added. The course was four weeks for both groups.\ Results\ After four week treatment, the total outcome of the treatment group was markedly superior to the control group ( u c=2.17,P <0.05). Conclusion\ Metoprolol is an effective medicine for congestive heart failure on the basis of routine therapy.
出处
《青岛大学医学院学报》
CAS
2003年第3期343-344,共2页
Acta Academiae Medicinae Qingdao Universitatis
